Harvest Technologies Introduces The SmartPrep 2 at The 88th Annual Meeting of The American Academy of Periodontology Being Held In New Orleans from September 25-27

Sep 24, 2002, 01:00 ET from Harvest Technologies Corporation

    PLYMOUTH, Mass., Sept 24 /PRNewswire/ -- Harvest Technologies Corporation
 (Plymouth MA) announced today that it will be introducing the SmartPrep 2
 System for the preparation and application of a biomaterial comprised of
 autologous concentrations of wound healing proteins derived from viable
 platelets, white blood cells and plasma. Some of the advanced features of the
 SmartPrep 2 system compared to the original SmartPrep system include: 1) A
 proprietary floating shelf design that is hematocrit independent thus allowing
 for the consistent preparation of product across diverse patient populations.
 2) The ability to process as little as 20cc of blood. 3) A lighter more
 operator friendly hardware component.
     "The SmartPrep 2 system offers the most predictable and effective
 autologous regenerative treatment available to the medical community today.
 That coupled with the systems practicable aspects of being an safe, cost-
 effective treatment option that is simple to operate and saves patient follow
 up time due to improved results will allow practitioners to incorporate
 regenerative therapy in a majority of their surgical procedures." Stated Dr
 Paul S. Petrungaro, DDS, MS.
     "We know of no other system that offers a customer the ability to produce
 consistently high levels of growth factors across diverse patient populations
 from such small volumes of blood in an automated easy to use format.
 Additionally, the SmartPrep 2 system offers the medical community the most
 cost effective therapeutic high dose end product available for the possibility
 of regenerating soft tissue and bone." Stated Gary Tureski, President of
     Johnson & Johnson through its subsidiary DePuy AcroMed will be the
 exclusive distributor of the SmartPrep 2 system worldwide under the name
 Symphony in the hospital based spinal, orthopedic and sports medicine markets.
 LifeCell Corporation (Nasdaq:   LIFC) will be exclusively marketing the
 SmartPrep 2 system to hospital-based ear, nose and throat (ENT), plastic and
 general surgeons in the United States. Harvest plans to market and distribute
 the SmartPRep 2 system to the dental, chronic wound and private clinic plastic
 and ENT markets.
     Harvest Technologies develops, manufactures and markets the SmartPrep
 System for the preparation and application of a biomaterial comprised of
 concentrations of wound healing proteins.  The SmartPrep system incorporates a
 proprietary hardware component and disposable kits along with various
 disposable applicators. Harvest Technologies goal is to improve patient
 outcome of orthopedic, plastic, ENT, and dental surgery as well as aid in the
 treatment of chronic wounds.
      Gary Tureski
      Harvest Technologies Corporation
                     MAKE YOUR OPINION COUNT -  Click Here

SOURCE Harvest Technologies Corporation